undamentalytics Newsletter
Sign in

DaVita income statement

In fiscal 2025, DaVita reported revenue of $13.64bn, up 6.5% on the year before, operating income of $2.04bn (a 15.0% margin) and net income of $747m, or $9.84 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue10.710.911.411.411.611.611.612.112.813.614.2
General and administrative1.11.11.11.11.21.21.41.51.51.71.7
Operating income2.01.81.51.61.71.81.31.62.12.02.1
Interest expense0.40.40.50.40.30.30.30.40.40.5—
Income before tax1.61.41.01.21.31.51.01.21.51.31.5
Income tax0.40.30.30.30.30.30.20.20.30.30.3
Net income0.90.70.20.80.81.00.60.70.90.70.9
Diluted EPS$4.29$3.47$0.92$5.27$6.31$8.90$5.85$7.42$10.73$9.84$13.55
Diluted shares (average)205m191m172m154m123m110m96m93m87m76m68m
EBITDA2.52.42.12.22.32.52.12.32.82.82.8

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DVA vs LHBTSG vs DVADGX vs DVA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from DaVita's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to DaVita.